GENB

Generate Biomedicines Inc

20.08

Aug 25 • 1:50 PM ET +2.36 (13.31%)

Healthcare Biotechnology USA Mid NASD

Today, 12:02 PMNo clear catalyst identified for GENB's ~20% surge on August 25

Peers: RYTM KYMR BMRN CRNX APGE INCY KRYS VKTX AXSM NBIX

| Held by: ARKG VTI IWM VXF IWO SBIO SCHA VTWO IWN ONEQ

Scroll to Statements

Index	RUT
Market Cap	2.58B
Enterprise Value	2.18B
Income	-
Sales	-
Book/sh	3.56
Cash/sh	3.56
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	312
IPO	Feb 27, 2026

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	5.65
P/C	5.63
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	8.30
Current Ratio	8.30
Debt/Eq	0.14
LT Debt/Eq	0.11
Option/Short	No / Yes

EPS (ttm)	-
EPS next Y	-2.29
EPS next Q	-0.56
EPS this Y	50.13%
EPS next Y	-1.25%
EPS next 5Y	26.09%
EPS past 3/5Y	- -
Sales past 3/5Y	- -
EPS Y/Y TTM	-
Sales Y/Y TTM	-
EPS Q/Q	-
Sales Q/Q	-
Earnings	Aug 06 BMO
EPS/Sales Surpr.	-2.30% 19.13%

Insider Own	57.06%
Insider Trans	14.72%
Inst Own	25.08%
Inst Trans	6.81%
ROA	-
ROE	-
ROIC	-
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	31.30%
SMA50	33.14%
SMA200	45.61%
Trades

Shs Outstand	128.27M
Shs Float	55.12M
Short Float	13.20%
Short Ratio	8.65
Short Interest	7.28M
52W High	18.18 10.45%
52W Low	11.00 82.54%
Volatility	8.18% 6.63%
ATR (14)	1.34
RSI (14)	76.72
Beta	-
Rel Volume	6.10
Avg Volume	841.12K
Volume	3,508,107

Perf Week	24.87%
Perf Month	46.78%
Perf Quarter	50.52%
Perf Half Y	-
Perf YTD	33.86%
Perf Year	-
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	1.00
Target Price	25.60
Prev Close	17.72
Price	20.08
Change %	13.31%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-13-26	Initiated	H.C. Wainwright	Buy	$16
Mar-24-26	Initiated	Piper Sandler	Overweight	$24
Mar-24-26	Initiated	Morgan Stanley	Overweight	$20
Mar-24-26	Initiated	Guggenheim	Buy	$30
Mar-24-26	Initiated	Goldman	Buy	$26
Mar-24-26	Initiated	Cantor Fitzgerald	Overweight

Today 11:10AM	Generate Biomedicines stock jumps as post-IPO lock-up set to expire (Proactive) +13.31%
Aug-17-26 12:12PM	Two Positions Make Up 80% of Nvidia's $63.4 Billion Portfolio (GuruFocus.com)
Aug-06-26 07:00AM	Generate Biomedicines Inc. Reports Second Quarter 2026 Financial Results and Provides Business Update (GlobeNewswire)
06:21AM	Generate Biomedicines: Q2 Earnings Snapshot (Associated Press)
Jul-10-26 08:57AM	Cathie Wood Dumps AMD, Doubles Down on Meta Stock (GuruFocus.com) -8.87%
09:04AM	Loading…
Jul-01-26 09:04AM	Cathie Wood Doubles Down on AI, Loads Up on Tesla, Palantir, and SpaceX (GuruFocus.com)
Jun-22-26 08:00AM	AdvanCell Signs 128,000 Square Foot, Full Building Lease at IQHQ's Innovation Park in Andover, Massachusetts (PR Newswire) +9.66%
May-28-26 04:20PM	Generate Biomedicines Inc. to Participate in Goldman Sachs 47th Annual Global Healthcare Conference (PR Newswire)
May-07-26 06:24AM	Generate Biomedicines: Q1 Earnings Snapshot (Associated Press) -11.21%
06:16AM	Generate Biomedicines, Inc. Reports First Quarter 2026 Financial Results and Provides Business Update (PR Newswire)

Generate Biomedicines, Inc. is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company was founded in 2018, and is headquartered in Somerville, MA.

Co-founder & Independent Chair of the BoardDr. Noubar B. Afeyan Ph.D.

CEO & DirectorMr. Michael T. Nally M.B.A.

M.D.Dr. Jason E. Silvers J.D.

Co-Founder & CTODr. Gevorg Grigoryan Ph.D.

Co-FounderMs. Molly Gibson Ph.D.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Nally Michael	Chief Executive Officer	Mar 04 '26	Buy	12.00	20,000	240,000	572,707	Mar 06 04:55 PM
Grous Beth	Chief People Officer	Mar 02 '26	Buy	16.00	300	4,800	300	Mar 02 06:05 PM
Silvers Jason	President & CFO	Mar 02 '26	Buy	16.00	2,000	32,000	1,000	Mar 02 05:54 PM
AFEYAN NOUBAR	Director	Mar 02 '26	Buy	16.00	4,687,500	75,000,000	15,264,724	Mar 02 05:52 PM
Mendillo Jane L	Director	Mar 02 '26	Buy	16.00	1,500	24,000	1,500	Mar 02 05:47 PM
AFEYAN NOUBAR	Director	Mar 02 '26	Buy	16.00	4,687,500	75,000,000	15,264,724	Mar 02 05:42 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

GENB

Generate Biomedicines Inc

Upgrade your Finviz experience